Current Report Filing (8-k)
May 25 2018 - 4:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 25, 2018 (May 24, 2018)
HealthStream, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Tennessee
|
|
000-27701
|
|
62-1443555
|
(State or Other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
209 10th Avenue South, Suite 450, Nashville, Tennessee 37203
(Address of principal executive offices) (Zip Code)
(615)
301-
3100
(Registrants telephone number, including area code)
Not Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging Company ☐
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 24, 2018, HealthStream, Inc. (the Company) held its annual meeting of shareholders (the Annual Meeting).
The final results of the proposals submitted to shareholder vote at the Annual Meeting, which proposals were described in more detail in the Companys Proxy Statement filed with the Securities and Exchange Commission on April 11, 2018, are
set forth below.
|
(1)
|
Election of three directors in Class III for a term of three years and until their successors are duly elected and qualified:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
|
WITHHELD
|
|
|
BROKER NON VOTES
|
|
Robert A. Frist, Jr.
|
|
|
27,950,539
|
|
|
|
326,547
|
|
|
|
3,642,252
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Frank Gordon
|
|
|
28,039,802
|
|
|
|
237,284
|
|
|
|
3,642,252
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C. Martin Harris, M.D.
|
|
|
28,174,485
|
|
|
|
102,601
|
|
|
|
3,642,252
|
|
In addition to the foregoing directors, the remaining directors not up for
re-election
at the Annual Meeting continue to serve on the Board of Directors.
|
(2)
|
Ratification of the appointment of Ernst & Young LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2018:
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON VOTES
|
31,688,620
|
|
166,432
|
|
64,286
|
|
0
|
|
(3)
|
Adoption of a
non-binding
advisory resolution on the Companys executive compensation as described in the Proxy Statement
(say-on-pay):
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON VOTES
|
27,798,196
|
|
416,663
|
|
62,227
|
|
3,642,252
|
|
(4)
|
Adoption of an advisory recommendation on the frequency with which the Company will conduct future
say-on-pay
votes:
|
|
|
|
|
|
|
|
One Year
|
|
Two Years
|
|
Three Years
|
|
BROKER NON VOTES
|
26,593,935
|
|
4,089
|
|
1,619,992
|
|
3,642,252
|
In light of the voting results with respect to the frequency of the advisory vote on executive compensation as set forth above
and the Companys recommendation that shareholders vote to hold future
say-on-pay
votes each year, the Company will continue to hold such votes each year until the
next required advisory vote on the frequency of such votes.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.
|
|
|
|
|
|
|
|
|
Date: May 25, 2018
|
|
|
|
HEALTHSTREAM, INC.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Gerard M. Hayden, Jr.
|
|
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
HealthStream (NASDAQ:HSTM)
Historical Stock Chart
From Aug 2024 to Sep 2024
HealthStream (NASDAQ:HSTM)
Historical Stock Chart
From Sep 2023 to Sep 2024